Abstract
BackgroundRemission or low disease activity (LDA) are the main treatment targets in Rheumatoid Arthritis (RA). Different remission criteria have been developed and differ between studies. The advent of biologic disease-modifying...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
